SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 167 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,948,000 | +45.0% | 108,513 | -4.7% | 0.02% | +63.6% |
| Q3 2017 | $1,343,000 | +10.2% | 113,822 | -1.9% | 0.01% | +10.0% |
| Q2 2017 | $1,219,000 | -4.5% | 116,067 | 0.0% | 0.01% | -9.1% |
| Q1 2017 | $1,277,000 | -18.8% | 116,067 | 0.0% | 0.01% | -15.4% |
| Q4 2016 | $1,573,000 | -7.9% | 116,067 | -16.3% | 0.01% | 0.0% |
| Q3 2016 | $1,707,000 | +12.2% | 138,700 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,522,000 | -44.0% | 138,700 | -44.2% | 0.01% | -50.0% |
| Q1 2016 | $2,716,000 | +232.4% | 248,500 | +426.0% | 0.03% | +225.0% |
| Q4 2015 | $817,000 | +2453.1% | 47,243 | +2865.7% | 0.01% | – |
| Q3 2015 | $32,000 | -99.2% | 1,593 | -99.3% | 0.00% | -100.0% |
| Q2 2015 | $3,821,000 | +68.4% | 232,553 | +59.5% | 0.05% | +80.8% |
| Q1 2015 | $2,269,000 | +35.6% | 145,810 | +24.5% | 0.03% | +36.8% |
| Q4 2014 | $1,673,000 | – | 117,110 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |